Evolent Reports Q1 2026 Earnings with Revenue Growth
Evolent Health (EVH) reported first-quarter revenue of $496 million for the period ending May 7, 2026. The company saw a sequential increase in total revenue by 9%, excluding the impact of its divestiture of Evolent Care Partnerships (ECP). Adjusted EBITDA matched expectations at $22 million.
Topics: contract_growth ebitda medical_expense_ratio revenue